<DOC>
	<DOCNO>NCT00889096</DOCNO>
	<brief_summary>1 . To evaluate effect single oral ( 80 mg ) dose propranolol encode emotional picture assess peripheral physiological electrocortical parameter healthy population . 2 . To evaluate effect single oral ( 80 mg ) dose propranolol retrieval emotional picture assess electrocortical parameter healthy population . 3 . To evaluate correlation behavioral data psychophysiological parameter .</brief_summary>
	<brief_title>Effects Propranolol Encoding Retrieval Emotional Material After Single Dose Administration Healthy Young Subjects</brief_title>
	<detailed_description>The main objective present study combine two line research investigate interaction emotional processing memory performance modulation beta-blockade . As suggested aforementioned lesion , pharmacological neuroimaging evidence , emotional stimulus well remember well encode . In ERP literature , number study emotion memory , investigated modulatory effect emotion memory , focus either stage encode ( Palomba , Angrilli &amp; Mini , 1997 ; Dolcos &amp; Cabeza , 2002 ) memory retrieval emotional neutral material ( Maratos &amp; Rugg , 2001 ; Windmann &amp; Kutas , 2001 ) . It assume emotionally arouse information gain privilege access processing resource . This mean emotional arouse stimulus guide attention elaborate processing , lead good memory formation . Concerning pharmacological manipulation ß-blockers , exist ERP study show effect ß-blockade encoding process memory retrieval emotional picture . Therefore , current investigation design test whether recall recognition emotional picture reduce administration propranolol whether reduction memory performance correlate change event-related potential peripheral physiological parameter ( heart rate variability , heart rate , blood pressure electrodermal response ) . As surrogate sympathetic activity and/or activation noradrenaline , salivary sample measure activity alpha-amylase employed ( van Stegeren , Rohleder , Everaerd &amp; Wolf , 2006 ) In conclusion , hypothesize ( 1 ) memory advantage emotionally arouse stimulus emotionally neutral picture . ( 2 ) ERP component associate emotional effect memory effect pronounce emotional stimulus . ( 3 ) Peripheral physiological parameter also pronounce emotionally arouse stimulus . ( 4 ) Emotional processing emotional memory impair beta-blocker propranolol indicate behavioral data psycho-physiological parameter .</detailed_description>
	<mesh_term>Propranolol</mesh_term>
	<criteria>age : 18 35 year sex : male ethnic origin : Caucasian body weight : 19 kg/m² 27 kg/m² [ calculate weight ( kg ) /height2 ( m2 ) ] good health evidence result clinical examination , ECG , laboratory checkup , judge clinical investigator differ clinical relevant way normal state write informed consent obstructive lung disease ( e.g . bronchial asthma ) peripheral arterial circulatory disturbance disturbance impulse formation conduction ( e.g . sick sinus syndrome , SA AVblockade ) bradycardia ( &lt; 50 beats/min ) hypotension ( systolic pressure &lt; 90 mmHg ) exist cardiac hematological disease and/or pathological finding , might interfere drug 's safety , tolerability , absorption and/or pharmacokinetics exist hepatic renal disease and/or pathological finding , might interfere drug 's safety , tolerability , absorption and/or pharmacokinetics exist gastrointestinal disease and/or pathological finding , might interfere drug 's safety , tolerability , absorption and/or pharmacokinetics exist disease CNS , especially epilepsy acute chronic disease could affect absorption metabolism history serious psychological disorder take MAO inhibitor drug alcohol dependence positive drug alcohol screen smoker positive antiHIVtest , HBsAgtest antiHCVtest volunteer diet could affect pharmacokinetics drug heavy tea coffee drinker ( 1L per day ) volunteer suspect know follow instruction volunteer work night shift volunteer stressful period undergone major life change ( e.g . death close family member past year ) volunteer unable understand write verbal instruction , particular regard risk inconvenience expose result participation study participation another clinical trial study le 14 day last acute disease systemically available medication within 4 week prior intend first administration unless terminal elimination halflife complete elimination body assume drug and/or primary metabolite repeat use drug last 4 week prior intend first administration , influence hepatic biotransformation ( e.g . barbiturate , cimetidine , phenytoin , rifampicin ) repeat use drug last 2 week prior intend first administration affect absorption ( e.g . laxative , metoclopramide , loperamide , antacid , H2receptor antagonists ) know allergic reaction active ingredient use constituent pharmaceutical preparation subject severe allergy multiple drug allergy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>memory</keyword>
	<keyword>heart rate</keyword>
	<keyword>skin conductance</keyword>
	<keyword>α-amylase</keyword>
	<keyword>propranolol</keyword>
	<keyword>tolerability</keyword>
</DOC>